论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Wang Y, Zhang R, Liu W
Received 29 April 2018
Accepted for publication 31 August 2018
Published 13 November 2018 Volume 2018:11 Pages 2249—2255
DOI https://doi.org/10.2147/IDR.S172598
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Dr Joachim Wink
Purpose: To study
the distribution of pathogenic bacteria in ventilator-associated pneumonia
(VAP), and epidemiological characteristics of extended-spectrum β lactamase
(ESBL)-producing bacteria.
Patients and methods: Lower
respiratory tract secretions from 156 patients with mechanical ventilation were
collected using a protective specimen brush (PSB), with quantitative bacterial
culture carried out and antibiotic sensitivity measured. ESBLs produced by
Gram-negative bacilli were detected using the double disk diffusion method and
monitored by plasmid profiles.
Results: Gram-negative
bacilli accounted for 78.9% of VAP pathogens, with Acinetobacter baumannii (25%), Pseudomonas aeruginosa (19.7%),
and Klebsiella
pneumoniae (14.5%) as the most common strains. There were 12
Gram-positive strains detected (15.8%); mostly methicillin-resistant. Staphylococcus aureus and
methicillin-resistant coagulase-negative Staphylococcus .
There were also four strains of Candida albicans detected (5.26%). Most
Gram-negative bacilli are sensitive to imipenem, but A. baumannii is
serious resistant. ESBLs were detected in nine strains of Gram-negative
bacilli; mainly produced by K. pneumoniae and Escherichia coli ,
to different degrees of multidrug resistance. Five strains of K. pneumoniae -producing
ESBLs were from the same clonal origin, as confirmed by plasmid restriction
endonuclease analysis.
Conclusion: VAP was mainly
caused by Gram-negative bacteria, with high antibiotic resistance rates.
Plasmids played an important role in the spread of antibiotic resistance among
bacteria.
Keywords: ventilator-associated
pneumonia, pathogenic bacteria, extended-spectrum β lactamases, drug resistance
plasmid